Calpain-mediated Cleavage of Collapsin Response Mediator Protein(CRMP)-2 During Neurite Degeneration in Mice
Overview
Affiliations
Axon or dendrite degeneration involves activation of the ubiquitin-proteasome system, failure to maintain neuritic ATP levels, microtubule fragmentation and a mitochondrial permeability transition that occur independently of the somal death programs. To gain further insight into the neurite degeneration mechanims we have compared two-dimensional gel electrophoresis patterns of neurite proteins from suprior cervical ganglia during degeneration caused by nerve growth factor (NGF) deprivation. We show here that collapsin response mediator protein (CRMP)-2 and CMRP-4 protein patterns were altered during beading formation, an early hallmark of neurite degeneration, prior to neurite fragmentation, the final stage of degeneration. Western blotting using a monoclonal antibody against CRMP-2 shows that the native form (64 kDa) was cleaved to generate a truncated form (58 kDa). No cleavage of CRMP-2 or -4 occurred in NGF-deprived neurites from Wld(s) (Wallerian degeneration slow) mutant mice in which neurite degeneration is markedly delayed. Using different protease inhibitors, purified calpain 1 protein and calpain 1-specific siRNA, we have demonstrated that CRMP-2 is a substrate for calpain 1. Indeed, caplain activity was activated at an early phase of neuronal degeneration in cerebellar granule neurons, and down-regulation of caplain 1 expression suppressed CRMP-2 cleavage. Furthermore, this cleavage occurred after vinblastine treatment or in vitro Wallerian degeneration, suggesting that it represents a common step in the process of dying neurites. CRMP-2 and -4 play a pivotal role in axonal growth and transport, and the C-terminus region of CRMP-2 is essential for its binding to kinesin-1. Hence, this cleavage will render them dysfunctional and subject to autophagic processing associated with beading formation, as evidenced by the finding that the truncated form was localized in the beadings.
Perez-Miller S, Gomez K, Khanna R ACS Pharmacol Transl Sci. 2024; 7(7):1916-1936.
PMID: 39022365 PMC: 11249630. DOI: 10.1021/acsptsci.4c00181.
Rao Z, Lin Z, Song P, Quan D, Bai Y Front Cell Neurosci. 2022; 16:926222.
PMID: 35836742 PMC: 9273721. DOI: 10.3389/fncel.2022.926222.
Nazareth L, St John J, Murtaza M, Ekberg J Front Cell Dev Biol. 2021; 9:660259.
PMID: 33898462 PMC: 8060502. DOI: 10.3389/fcell.2021.660259.
Balakrishnan A, Belfiore L, Chu T, Fleming T, Midha R, Biernaskie J Front Mol Neurosci. 2021; 13:608442.
PMID: 33568974 PMC: 7868393. DOI: 10.3389/fnmol.2020.608442.
Girouard M, Simas T, Hua L, Morquette B, Khazaei M, Unsain N eNeuro. 2020; 7(2).
PMID: 32001550 PMC: 7053045. DOI: 10.1523/ENEURO.0479-19.2020.